The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

Youngji Jo, David Wesley Dowdy

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)675-676
Number of pages2
JournalThe Lancet Infectious Diseases
Volume19
Issue number7
DOIs
StatePublished - Jul 1 2019

Fingerprint

Typhoid-Paratyphoid Vaccines
Conjugate Vaccines
Economics
Incidence
Infection

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection. / Jo, Youngji; Dowdy, David Wesley.

In: The Lancet Infectious Diseases, Vol. 19, No. 7, 01.07.2019, p. 675-676.

Research output: Contribution to journalComment/debate

@article{31f6c8acab584681b255090a3de66212,
title = "The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection",
author = "Youngji Jo and Dowdy, {David Wesley}",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/S1473-3099(19)30054-4",
language = "English (US)",
volume = "19",
pages = "675--676",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "7",

}

TY - JOUR

T1 - The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

AU - Jo, Youngji

AU - Dowdy, David Wesley

PY - 2019/7/1

Y1 - 2019/7/1

UR - http://www.scopus.com/inward/record.url?scp=85067865224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067865224&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(19)30054-4

DO - 10.1016/S1473-3099(19)30054-4

M3 - Comment/debate

C2 - 31130328

AN - SCOPUS:85067865224

VL - 19

SP - 675

EP - 676

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 7

ER -